No Stock Yet
REVBW REVELATION BIOSCIENCES INC C/WTS 10/01/2027 (TO PUR COM)
0.020+0.001+5.26%
YOY
Do not show
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Financial Ratios
Efficiency Ratios TTM
ROA
--
-216.223%
--
-369.675%
--
-200.390%
--
-359.824%
Efficiency Ratios
Profitability Ratios TTM
Financial Health Ratios
Total Assets to Common Equity
--
296.339%
--
--
--
--
--
--
Debt to Asset Ratio
--
0.000%
--
--
--
--
--
--
Current Ratio
-42.24%
1.4873
--
0.6756
--
0.9743
-76.64%
0.8928
Quick Ratio
-24.19%
1.4165
--
0.5796
--
0.8896
-83.98%
0.5952
GrowthRatios
Growth Ratios
Currency Unit
USDUSDUSDUSD
FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.
Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.
The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%
Company Overview
More
CEO： Mr. James Rolke
Market： NASDAQ
Listing Date： 10/08/2020
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist